134 related articles for article (PubMed ID: 2168468)
1. Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients.
Eriksson B; Arnberg H; Lindgren PG; Lörelius LE; Magnusson A; Lundqvist G; Skogseid B; Wide L; Wilander E; Oberg K
J Intern Med; 1990 Aug; 228(2):103-13. PubMed ID: 2168468
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients.
Eriksson B; Oberg K; Skogseid B
Acta Oncol; 1989; 28(3):373-7. PubMed ID: 2472825
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.
Nikou GC; Marinou K; Thomakos P; Papageorgiou D; Sanzanidis V; Nikolaou P; Kosmidis C; Moulakakis A; Mallas E
Pancreatology; 2008; 8(4-5):510-9. PubMed ID: 18765956
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
5. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and therapy monitoring of liver metastases from neuroendocrine tumours.
Andersson T
Acta Radiol Suppl; 1991; 375 ( Pt 2)():91-107. PubMed ID: 1726275
[No Abstract] [Full Text] [Related]
7. A case of dopamine agonists inhibiting pancreatic polypeptide secretion from an islet cell tumor.
Pathak RD; Tran TH; Burshell AL
J Clin Endocrinol Metab; 2004 Feb; 89(2):581-4. PubMed ID: 14764765
[TBL] [Abstract][Full Text] [Related]
8. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.
Gullo L; Migliori M; Falconi M; Pederzoli P; Bettini R; Casadei R; Delle Fave G; Corleto VD; Ceccarelli C; Santini D; Tomassetti P
Am J Gastroenterol; 2003 Nov; 98(11):2435-9. PubMed ID: 14638345
[TBL] [Abstract][Full Text] [Related]
9. Biochemical diagnosis of gastroenteropancreatic endocrine tumors.
Tartaglia A; Bianchini S; Vezzadini P
Minerva Med; 2003 Feb; 94(1):1-7. PubMed ID: 12719697
[TBL] [Abstract][Full Text] [Related]
10. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
11. Role of chemoembolization in synchronous liver metastases from pancreatic endocrine tumours.
Falconi M; Bassi C; Bonora A; Sartori N; Procacci C; Talamini G; Mansueto GC; Pederzoli P
Dig Surg; 1999; 16(1):32-8. PubMed ID: 9949265
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area.
Madeira I; Terris B; Voss M; Denys A; Sauvanet A; Flejou JF; Vilgrain V; Belghiti J; Bernades P; Ruszniewski P
Gut; 1998 Sep; 43(3):422-7. PubMed ID: 9863490
[TBL] [Abstract][Full Text] [Related]
13. hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids.
Oberg K; Wide L
Acta Endocrinol (Copenh); 1981 Oct; 98(2):256-60. PubMed ID: 6117168
[TBL] [Abstract][Full Text] [Related]
14. [Insulinoma].
Krysiak R; Okopień B; Herman ZS
Pol Merkur Lekarski; 2007 Jan; 22(127):70-4. PubMed ID: 17477096
[TBL] [Abstract][Full Text] [Related]
15. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
[TBL] [Abstract][Full Text] [Related]
16. Endocrine pancreatic carcinoma.
Rothmund M; Stinner B; Arnold R
Eur J Surg Oncol; 1991 Apr; 17(2):191-9. PubMed ID: 1849844
[TBL] [Abstract][Full Text] [Related]
17. MRI of pancreatic islet cell carcinoma.
Carlson B; Johnson CD; Stephens DH; Ward EM; Kvols LK
J Comput Assist Tomogr; 1993; 17(5):735-40. PubMed ID: 8396599
[TBL] [Abstract][Full Text] [Related]
18. [Role of MRI in the diagnosis of endocrine tumors of the pancreas].
Carrière F; Legmann P; Hazebroucq V; Abecassis JP; Pariente D; Bonnin A
J Radiol; 1992 Apr; 73(4):235-42. PubMed ID: 1322460
[TBL] [Abstract][Full Text] [Related]
19. [A 42-year-old patient with a metastasizing insulinoma].
Sedlmayr P; Eber B; Kullnig P; Klimpfinger M
Wien Med Wochenschr; 1987 Jun; 137(12):275-7. PubMed ID: 3039747
[TBL] [Abstract][Full Text] [Related]
20. [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure].
Olausson M; Friman S; Johanson V; Nilsson O; Wängberg B; Ahlman H
Lakartidningen; 1999 Sep; 96(36):3783-6. PubMed ID: 10500396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
